{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-098376","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2025-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.590702+00:00","generated_at":"2026-05-17T04:13:45.674581+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Gain Therapeutics director Eric Richman resigns from board without disagreement; board reduced to seven","bullets":["Eric Richman resigned from the Board effective October 6, 2025.","Resignation was not due to any disagreement with company operations, policies, or practices.","Board size reduced from eight to seven members on October 7, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-098376","json":"https://secwatch.observer/filing/0001104659-25-098376.json","markdown":"https://secwatch.observer/filing/0001104659-25-098376.md","text":"https://secwatch.observer/filing/0001104659-25-098376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465925098376/0001104659-25-098376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465925098376/tm2528203d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:13:45.674581+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}